CheckMyRecalls

ENDO USA, Inc. recalls Buprenorphine Hydrochloride

Published
20 May 2026
Units affected
34,293 vials
Agency
FDA
Country
United States

The hazard

Crystallization; identified as Buprenorphine free base

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.

Brand / company
ENDO USA, Inc.
Codes / lots
Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 20 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.